DexCom Inc. Stock Underperforms Friday When Compared To Competitors

Evans Bancorp Inc

Change company Symbol lookup

Select an option...

EVBN Evans Bancorp Inc

CTXS Citrix Systems Inc

RY Royal Bank of Canada

MCIOF MCI Onehealth Technologies Inc

ADOCW Edoc Acquisition Equity Warrants Exp 30th Nov 2027 *W EXP 11/30/2027

C Citigroup Inc

CVX Chevron Corp

CDNS Cadence Design Systems Inc

STRL Sterling Construction Company Inc

AIHS Senmiao Technology Ltd

Financials : Banks | Small Cap Value

Company profile

Evans Bancorp, Inc. is a financial holding company. The Company conducts its business through its subsidiaries, such as Evans Bank, N.A. (the Bank), which provides a range of banking services to consumer and commercial customers in Western New York and the Finger Lakes Region, and Evans National Financial Services, LLC (ENFS), which hold interests in The Evans Agency, LLC (TEA), which sells various premium-based insurance policies on a commission basis. Its segments include banking activities and insurance agency activities. The banking activities segment includes both commercial and consumer banking services, including a range of lending and depository services as well as offering non-deposit investment products, such as annuities and mutual funds. The insurance agency activities segment includes the activities of selling various premium-based insurance policies on a commission basis, including business and personal insurance, employee benefits, surety bonds, and risk management.

DexCom Inc. Stock Underperforms Friday When Compared To Competitors

4:50 pm ET January 21, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DexCom Inc. (DXCM) slid 2.89% to $422.10 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.89% to 4,397.94 and Dow Jones Industrial Average falling 1.30% to 34,265.37. This was the stock's second consecutive day of losses. DexCom Inc. closed $237.35 below its 52-week high ($659.45), which the company achieved on November 18th.

The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.23% to $164.87, Abbott Laboratories (ABT) rose 0.90% to $125.83, and Medtronic PLC (MDT) fell 0.48% to $105.60. Trading volume (900,566) eclipsed its 50-day average volume of 816,072.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 21, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 21, 2022 16:50 ET (21:50 GMT)